Landmark Alzheimer's drug approval confounds research community

Many scientists say there is not enough evidence that Biogen's aducanumab is an effective therapy for the disease. Many scientists say there is not enough evidence that Biogen's aducanumab is an effective therapy for the disease.
Author(s): Asher Mullard Author Affiliations: Landmark Alzheimer's drug approval confounds research community Plaques of amyloid-[beta] in the brain are one target of Alzheimer's disease treatments. Credit: Thomas Deerinck, NCMIR/SPL Amyloid [...]